Home › Diffuse Intrinsic Pontine Glioma › North Carolina › Durham
Diffuse Intrinsic Pontine Glioma clinical trials in Durham, NC
9 studies for Diffuse Intrinsic Pontine Glioma are looking for participants at sites in and around Durham (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas
RecruitingPhase 2
- Duke University Medical Center, Durham
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
RecruitingPhase 1/2
- Duke University Medical Center, Durham
Targeted Pediatric High-Grade Glioma Therapy
RecruitingObservational study
- Duke University Health System, Durham
Study of Olutasidenib and Temozolomide in HGG
RecruitingPhase 2
- Duke University Health System, Durham
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
RecruitingPhase 2
- Duke Cancer Center, Durham
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
RecruitingEarly phase 1Healthy volunteers welcome
- Duke University Health System, Durham
Combination Therapy for the Treatment of Diffuse Midline Gliomas
RecruitingPhase 2
- Duke University, Durham
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
RecruitingPhase 2
- Duke University Health System, Durham
A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion
RecruitingEarly phase 1
- Duke University Health System, Durham
Diffuse Intrinsic Pontine Glioma trials in other cities
- Washington, DC11 studies
- Seattle, WA10 studies
- Philadelphia, PA10 studies
- Columbus, OH10 studies
- Cincinnati, OH10 studies
- Houston, TX10 studies
- Chicago, IL9 studies
- Boston, MA9 studies
- Aurora, CO8 studies
- Miami, FL6 studies
- Ann Arbor, MI6 studies
- St. Louis, MO5 studies
Other studies in Durham
- Breast Cancer64 studies
- Cancer (all types)58 studies
- Non-Small Cell Lung Cancer39 studies
- Multiple Myeloma37 studies
- Acute Myeloid Leukemia33 studies
- Metastatic Cancer33 studies
- Prostate Cancer32 studies
- Lung Cancer32 studies
- Colorectal Cancer28 studies
- Ovarian Cancer27 studies
- Chronic Lymphocytic Leukemia27 studies
- Heart Failure26 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.